Compounds > 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea
Page last updated: 2024-08-23

1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and Vomiting

1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea has been researched along with Vomiting in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cornbleet, MA; Kerr, ME; Leonard, RC; Macpherson, JS; Smyth, JF; Warrington, PS; Whelan, JM1

Other Studies

1 other study(ies) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and Vomiting

ArticleYear
Phase I study of TCNU, a novel nitrosourea.
    European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Evaluation; Female; Hematologic Diseases; Humans; Male; Middle Aged; Nausea; Neoplasms; Nitrosourea Compounds; Taurine; Vomiting

1987